Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutics development for addiction: Orexin-1 receptor antagonists
David A. Perrey, Yanan Zhang
Brain Research (2018) Vol. 1731, pp. 145922-145922
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Synthesis and characterization of a new Positron emission tomography probe for orexin 2 receptors neuroimaging
Ping Bai, Yan Liu, Yulong Xu, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105779-105779
Open Access | Times Cited: 10
Identifying roles for peptidergic signaling in mice
Kathryn G. Powers, Xin‐Ming Ma, Betty Eipper, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 40, pp. 20169-20179
Open Access | Times Cited: 16
Selective orexin 1 receptor antagonist SB-334867 aggravated cognitive dysfunction in 3xTg-AD mice
Wen-Rui Gao, Xiaohong Hu, Kai-Yue Yu, et al.
Behavioural Brain Research (2022) Vol. 438, pp. 114171-114171
Closed Access | Times Cited: 9
Estradiol-dependent hypocretinergic/orexinergic behaviors throughout the estrous cycle
Hye Ji J. Kim, Samuel A. Dickie, Robert B. Laprairie
Psychopharmacology (2022) Vol. 240, Iss. 1, pp. 15-25
Open Access | Times Cited: 9
Hypocretin (Orexin) Replacement Therapies
Erica Seigneur, Luı́s de Lecea
Medicine in Drug Discovery (2020) Vol. 8, pp. 100070-100070
Open Access | Times Cited: 12
Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation
Rosa Maria Vitale, Fabio Arturo Iannotti, Aniello Schiano Moriello, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1134-1134
Open Access | Times Cited: 11
The role of orexin receptors within the CA1 area in the acquisition and expression of methamphetamine place preference
Fazel Moshrefi, Amir Mohammad Farrokhi, Mojdeh Fattahi, et al.
Journal of Psychiatric Research (2024) Vol. 172, pp. 291-299
Closed Access | Times Cited: 1
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 1
Healthy Sleep, Orexin System and Addiction
Ana Clementina Equihua-Benítez, Fabio García‐García
Revista Internacional de Investigación en Adicciones (2024) Vol. 10, Iss. 1, pp. 80-90
Closed Access | Times Cited: 1
Potential therapeutic targets for the treatment of opioid abuse and pain
Norikazu Kiguchi, Mei‐Chuan Ko
Advances in pharmacology (2022), pp. 335-371
Closed Access | Times Cited: 7
Neural correlates and potential targets for the contribution of orexin to addiction in cortical and subcortical areas
Masoumeh Kourosh‐Arami, Masoumeh Gholami, Seyed Sajjad Alavi-Kakhki, et al.
Neuropeptides (2022) Vol. 95, pp. 102259-102259
Closed Access | Times Cited: 6
Synthesis and biological evaluation of novel 18F-labeled phenylbenzofuran-2-carboxamide derivative for detection of orexin 1 receptor in the brain
Hiroyuki Watanabe, Yuki Idoko, Shimpei Iikuni, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 43, pp. 128098-128098
Closed Access | Times Cited: 7
Substituted Azabicyclo[2.2.1]heptanes as Selective Orexin-1 Antagonists: Discovery of JNJ-54717793
Cathy Préville, Pascal Bonaventure, Tatiana Koudriakova, et al.
ACS Medicinal Chemistry Letters (2020) Vol. 11, Iss. 10, pp. 2002-2009
Open Access | Times Cited: 7
Association of orexin/hypocretin receptor gene (HCRTR1) with reward sensitivity, and interaction with gender
Aleksander Pulver, Evelyn Kiive, Margus Kanarik, et al.
Brain Research (2020) Vol. 1746, pp. 147013-147013
Open Access | Times Cited: 7
Nonclinical evaluation of abuse liability of the dual orexin receptor antagonist lemborexant
Shoji Asakura, Motohiro Shiotani, David V. Gauvin, et al.
Regulatory Toxicology and Pharmacology (2021) Vol. 127, pp. 105053-105053
Open Access | Times Cited: 6
Lateral hypothalamic orexin neurons mediate electroacupuncture-induced anxiolytic effects in a rat model of post-traumatic stress disorder
Jiaqi Lü, Chuan Qin, Can Wang, et al.
Brain Research Bulletin (2023) Vol. 201, pp. 110712-110712
Open Access | Times Cited: 2
Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil
Aida Mohammadkhani, Morgan H. James, Gary Aston‐Jones
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 5
Choline-Sigma-1R as an Additional Mechanism for Potentiation of Orexin by Cocaine
Jeffrey L. Barr, Pingwei Zhao, G. Cristina Brailoiu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5160-5160
Open Access | Times Cited: 5
The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task
Joost Wiskerke, Morgan H. James, Gary Aston‐Jones
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 4
Novel 5-Alkyl Pyrrolidine Orexin Receptor Agonists for Treating Sleep Disorders
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2020) Vol. 11, Iss. 11, pp. 2085-2086
Open Access | Times Cited: 4
Neurobiology of Dream Activity and Effects of Stimulants on Dream
Eric Murillo-Rodrı́guez, Astrid Coronado-Álvarez, Luis Angel López-Muciño, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 15, pp. 1280-1295
Closed Access | Times Cited: 3
A novel, non-opioid, selective orexin-1 receptor antagonist for the treatment of substance use disorders
Clare Murray, Jennifer Fox, Christian Heidbreder, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104053-104053
Open Access
Improving Sleep to Address Co-Occurring Substance Use Disorder and Chronic Pain: Exploring the Potential of the Orexin (Hypocretin) System as a Clinical Target
Chung Jung Mun, Matthew J. Reid, Sarah Sarandos, et al.
Current Addiction Reports (2024)
Closed Access
Cell‐type specific knockout of peptidylglycine α‐amidating monooxygenase reveals specific behavioral roles in excitatory forebrain neurons and cardiomyocytes
Kathryn G. Powers, Xin‐Ming Ma, Betty Eipper, et al.
Genes Brain & Behavior (2020) Vol. 20, Iss. 2
Open Access | Times Cited: 3
Nucleus accumbens shell Orexin-1 receptors are not needed for single-bottle limited daily access alcohol intake in C57BL/6 mice
Kelly Lei, Claudina Kwok, F. Woodward Hopf
Alcohol (2020) Vol. 89, pp. 139-146
Open Access | Times Cited: 3

Scroll to top